CD19 and neoplasm: To this end we first determined the level of CAR T cell-mediated trogocytosis in five common B cell malignancies and found that all tumor cells experienced substantial levels of trogocytosis leading to the emergence of CD19neg tumor cells when treated with high affinity CD19 CAR T cells (Fig. 2A).